Market Analysis

Real-time market data and insights.

📰 NVO Latest News

Last Updated: 2026.05.11 07:15:31
Recent Headlines
The Next Generation of the GLP-1 Revolution Is Already Underway
GlobeNewsWire 2026-05-11 7:15 AM
Novo Nordisk: Flipping The Script
SeekingAlpha 2026-05-10 3:34 PM
Novo Nordisk: Misread Q1 Earnings, Mispriced Stock
SeekingAlpha 2026-05-06 5:24 PM
Novo Nordisk A/S (NOVO:CA) Q1 2026 Earnings Call Transcript
SeekingAlpha 2026-05-06 4:21 PM
Novo Nordisk A/S 2026 Q1 - Results - Earnings Call Presentation
SeekingAlpha 2026-05-06 11:32 AM
Viking Therapeutics: Market Betting On Big Upside Through 2030
SeekingAlpha 2026-05-05 4:00 PM
Eli Lilly: No Big Gap To Competition
SeekingAlpha 2026-05-05 10:29 AM
Novo Nordisk: A Generational Buying Opportunity Ahead Of Q1 Earnings
SeekingAlpha 2026-05-04 12:33 PM
Eli Lilly: Buying Opportunity Knocking On The Front Door Again (Rating Upgrade)
SeekingAlpha 2026-05-01 12:31 PM
Novo Nordisk: Pricing Pressure And Falling Margins Make This A Value Trap (Q1 Earnings Preview)
SeekingAlpha 2026-04-30 11:45 AM
Eli Lilly: A Heavyweight Battle Isn't Won In Round 1
SeekingAlpha 2026-04-24 8:21 PM
Novo Nordisk: Is The GLP‑1 Golden Age Already Behind It?
SeekingAlpha 2026-04-22 10:25 AM
Novo Nordisk's Weight Loss Doesn't Mean To Load Up
SeekingAlpha 2026-04-15 2:06 PM
Novo Nordisk: Don't Stop Purchasing The Dip
SeekingAlpha 2026-04-13 3:37 PM
EDEN: No Longer Expensive, But Not Much Incentive To Turn Bullish Either
SeekingAlpha 2026-04-10 2:33 AM
Eli Lilly Vs. Amgen: Who Leads Obesity And IMIDs
SeekingAlpha 2026-04-09 1:53 PM
Hims & Hers Health Is No Longer What The Market Thinks
SeekingAlpha 2026-04-08 2:13 PM
Novo Nordisk A/S (NOVO:CA) Shareholder/Analyst Call Transcript
SeekingAlpha 2026-03-26 9:05 PM
Novo Nordisk: Priced For Disaster
SeekingAlpha 2026-03-23 3:35 PM
Eli Lilly Vs. Novo Nordisk: The Valuation Gap Is Unreasonable
SeekingAlpha 2026-02-27 8:13 PM
Why I'm Still Bullish On Novo Nordisk Despite Recent Setbacks
SeekingAlpha 2026-02-27 11:33 AM
🔮
Keep Stock Illuminati Free

100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.

One-time or recurring — every dollar helps us add more data & features.

NVO Tools
Dashboard Insider Trading Institutional SEC Filings Short Interest News Options
🔮
Keep Stock Illuminati Free

100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.

PayPal Donate via PayPal
☕ $5 📊 $10 🚀 $25

One-time or recurring — every dollar helps us add more data & features.

🔮
Keep Stock Illuminati Free

100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.

PayPal Donate via PayPal
☕ $5 📊 $10 🚀 $25

One-time or recurring — every dollar helps us add more data & features.